Thelma Therapeutics (XKRX:015540) Interest Expense : ₩-1,671 Mil (TTM As of Sep. 2022)

View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Thelma Therapeutics's interest expense for the three months ended in Sep. 2022 was ₩ -390 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2022 was ₩-1,671 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Thelma Therapeutics's Operating Income for the three months ended in Sep. 2022 was ₩ -593 Mil. Thelma Therapeutics's Interest Expense for the three months ended in Sep. 2022 was ₩ -390 Mil. Thelma Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Thelma Therapeutics Interest Expense Historical Data

The historical data trend for Thelma Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Interest Expense Chart

Thelma Therapeutics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Interest Expense

Get a 7-Day Free Trial

-502.22

-541.92

-3,852.71

-2,642.19

-2,811.45

Thelma Therapeutics Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Interest Expense	Get a 7-Day Free Trial															-571.32	-590.49	-327.60	-362.51	-390.24

Thelma Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,671 Mil.

Thelma Therapeutics (XKRX:015540) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Thelma Therapeutics's Interest Expense for the three months ended in Sep. 2022 was ₩-390 Mil. Its Operating Income for the three months ended in Sep. 2022 was ₩-593 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2022 was ₩0 Mil.

Thelma Therapeutics's Interest Coverage for the quarter that ended in Sep. 2022 is calculated as

Thelma Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Thelma Therapeutics (XKRX:015540) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR

Website

http://www.medi-plant.co.kr

Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines